CANCER GENETICS, INC company info

CIK 1349929
IRS Number 043462475
State of incorporation DE
Business address 201 ROUTE 17 NORTH
2ND FLOOR
RUTHERFORD
NJ
07070
Mail address 201 ROUTE 17 NORTH
2ND FLOOR
RUTHERFORD
NJ
07070

Short summary

CANCER GENETICS, INC is a New Jersey company, with head office located at 201 Route 17 North Rutherford, New Jersey 07070. In 2018 the company owned a total of 38.49 million USD worth of assets, including 10.33 million USD worth of current assets. 2013 was the year when the company amassed the most assets.

CANCER GENETICS, INC Income Statement

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Gross Profit -0.99-0.100.371.691.753.949.9511.058.75
Research and development 1.172.072.112.194.625.485.974.792.49
Operating Expenses 5.338.098.0110.1520.9525.3226.6729.6730.72
Operating Income (Loss) -6.32-8.18-7.64-8.46-19.21-21.38-16.72-18.62-21.98
Interest expense 0.791.314.702.390.470.340.452.132.12
Other Nonoperating Income (Expense) -2.08-11.700.97
Income Tax Expense (Benefit) -0.66-0.66-2.35-1.180-2.080
Net income -8.41-19.89-6.67-12.37-16.64-20.18-15.80-20.88-20.37

CANCER GENETICS, INC Balance Sheet

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Cash and cash equivalents 0.031.780.401.9437.4223.7410.556.171.600.70
Accounts Receivable, Net, Current 0.691.262.065.7211.9413.169.367.29
Inventories 0.230.200.280.130.150.140.14
Property, Plant and Equipment, Gross 2.802.963.577.3310.4611.0913.7113.24
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 1.661.992.312.894.396.368.169.18
Goodwill 03.1912.0312.0317.2617.26
Intangible Assets, Net (Excluding Goodwill) 1.641.404.283.92
Other Assets, Noncurrent 2.521.697.434.8414.4014.3622.4324.34
Total assets 7.036.4649.6039.8344.2440.9541.3738.49
Current assets 3.383.9140.6931.1024.4721.8714.2010.33
Total current liabilities 4.4512.642.374.8310.139.1121.5428.32
Long-term Debt 6
Deferred Revenue, Noncurrent 00.800.750.440.99
Total liabilities 26.1013.329.1413.0615.0822.3224.0930.81
Common Stock, Value, Issued 0.000.000.000.000.000.000.000.01
Retained Earnings (Accumulated Deficit) -42.27-55.73-68.00-87.23-107.43-126.30-145.43-162.33
Accumulated Other Comprehensive Income (Loss), Net of Tax 00.13-0.02

CANCER GENETICS, INC Cash Flow

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Net income -8.41-19.89-6.67-12.37-16.64-20.18-15.80-20.88-20.37
Depreciation 0.320.360.340.310.811.502.031.801.60
Deferred Income Tax Expense (Benefit)
Accounts receivable 0.570.360.160.721.661.665.853.58-1.04
Net Cash Provided by (Used in) Operating Activities -5.73-5.07-7.58-8.08-12.34-13.60-17.85-13.56-12.55
Payments to Acquire Property, Plant, and Equipment 0.160.270.160.261.371.010.491.280.65
Payments to Acquire Businesses, Net of Cash Acquired 03.18001.090
Payments to Acquire Intangible Assets 0.020.080.140.090.130.140.120.130.03
Net Cash Provided by (Used in) Investing Activities -0.17-0.11-0.35-1.40-11.37-2.64-0.61-2.701.08
Proceeds from Issuance of Common Stock 0.03
Net Cash Provided by (Used in) Financing Activities 7.655.826.3358.11-0.2010.148.5016.342.15
Cash and Cash Equivalents, Period Increase (Decrease) 1.750.64-1.6048.64-23.91-6.10-9.960.04